Reinventing Healthcare Together
Weavr Health seeks to partner across a wide range of health and wellness applications. Our platform accelerates efforts to improve patient/provider engagement, improve access and quality and lower costs through value-based care and other new approaches.
Our current partners and those in development include diagnostic manufacturers, direct-to-consumer organizations, universities, research labs, government agencies, telemedicine companies, healthcare institutions, and more.
From broad deployment of our Velvet blood collection device for easy home sample collection to our own diagnostic solutions, we can support a variety of monitoring, research and care delivery approaches.
These approaches include tracking of health levels, providing information to make informed lifestyle decisions, and managing chronic disease from home in consultation with clinicians. Velvet makes it possible to collect blood samples without the need for skilled personnel, special on-site equipment, an expensive refrigerated supply chain, or costly onsite collection.
Weavr Health offers the Velvet device for studies, with the intended use to discover and develop medical knowledge related to a human disease and conditions of focus.
Test the Velvet technology in your laboratory
Please contact partnerships@weavrhealth.com to request samples.
The Weavr Health team is available to support you whether you want to perform a feasibility assessment or are ready to validate for commercial launch.
Join us to pilot an automation study. The Weavr Health development pipeline has tailored options of device openers- ranging from manual openers to full automation instrumentation for high throughput labs. Please contact partnerships@weavrhealth.com if you are interested in testing our semi-automated work cell capable of processing 1000+ devices per 8-hour shift.
Analyze aggregate data: Weavr Health Digital Application and Online Dashboard
Weavr Health supports partners with solutions to integrate data and interpret results.
Track results and generate insights across broad populations. Deidentified and aggregated data defines seroprevalence at a population level. Intuitive data access and comprehensive evaluation enable robust epidemiological studies. Insights may be used to inform guidelines and policy decision-making and provide perspective about how to stratify risk.

Participate in a seroprevalence study with your organization or community today!
With our Silk™ COVID-19 Rapid Antibody Test, we are currently offering the opportunity to participate in a seroprevalence study.
.
*Silk COVID-19 Rapid Antibody Test is For Investigational Use Only. The performance characteristics of this product have not been established.